B-North Unquoted SME lender with unique proposition

Hardman & Co

B-North is raising capital ahead of getting its banking licence (due spring 2020). It will then attack the huge, profitable and poorly-served SME lending market. B-North combines i) state-of-the-art technology (built from scratch to address customers’ needs), ii) offering the £20bn+ p.a. commercial broker market an unparalleled service and an innovative remuneration model, and iii) experienced bankers based in empowered regional hubs. It should be more efficient than its peers, and will use technology to be close to customers. The financial model assumes a market share of just 2.5% in 2027. Delivery of this sees a highly profitable, and valuable, business, in our view.

  • Near-term capital raises:  B-North is currently raising up to £2m through private subscriptions through the Growthfunders and Crowdcube platforms. It anticipates raising a further £20m (through Berenberg), conditional on the approval of the banking licence due in March 2020. Further raises are planned.
  • “Reality-check”:  We have reviewed the company assumptions and believe them to be ambitious but credible. We have considered the absolute performance and the level of lending that peers have achieved. Importantly, B-North has multiple options to address any volume shortfall – most at a modest cost.
  • Valuation:  Given the growth profile of the company and associated uncertainties, any valuation must be treated with extreme caution. We provide a range of approaches (p46-48) that, on average, indicate B-North’s value in 2027 could be treble the amount of equity raised. We also provide a range of sensitivities.
  • Risks:  Credit risk is key for any bank. B-North will establish independent credit functions, and its technology will bring it close to customers interfacing directly with its management information. It has multiple options to address any loan growth shortfall. The economic cycle is important. The model is yet to be tested.
  • Investment summary:  B-North is still at the pre-revenue stage. Its model should be low-cost and deliver a superior service to customers and intermediaries. It has a conservative credit culture and uses state-of-the-art technology, written from scratch, to originate, service and manage its business. Funding will be via the deep best-buy retail deposit comparison sites. The potential market is huge, profitable and under-served, and major incumbents have selectively become uncompetitive.

DOWNLOAD THE FULL REPORT

Share on:

Latest Company News

RM sharpens its assessment strategy around candidate experience

RM is strengthening its assessment proposition by focusing on how awarding bodies can improve accessibility, trust and the overall candidate experience.

Record builds international private markets reach with Sharia-compliant platform

Record Amanah gives the group a dedicated platform for developing Sharia-compliant private market investments with Khalij Group.

Genflow Biosciences moves longevity programme towards its next test

Genflow Biosciences has reported better survival rates and no adverse events three months into its ageing-dog gene therapy study.

Drax extends the life of a key Scottish hydro asset

Drax has completed a £2 million refurbishment of Tongland Power Station as part of its wider programme to maintain and upgrade long-life renewable energy assets.

Unilever’s award-winning marketing supports its brand-led growth strategy

Unilever’s 2026 Cannes Lions campaigns show how the group is using consumer behaviour and local relevance to support its major brands.

Biotech Growth Trust notes $2.2 billion acquisition of Forte Biosciences

Argenx has agreed to acquire BIOG portfolio company Forte Biosciences for $77 per share in cash, representing a 40.5% premium. Forte accounted for 3.03% of the Company’s NAV at the time of the announcement.

    Search